Welcome to our dedicated page for Tactile Systems SEC filings (Ticker: TCMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Tactile Systems Technology, Inc. (Tactile Medical) SEC filings page for ticker TCMD provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Nasdaq-listed medical technology company incorporated in Delaware, Tactile Medical files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K under Commission File Number 001-37799.
Through these filings, investors can review detailed information on Tactile Medical’s business, including its focus on at-home therapies for lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. Periodic reports describe revenue from sales and rentals of the lymphedema product line and sales of the airway clearance product line, along with discussions of gross margin, operating expenses, net income or loss and non-GAAP measures such as Adjusted EBITDA as defined by the company.
Current reports on Form 8-K document material events, such as the release of quarterly financial results and the authorization of share repurchase programs for the company’s common stock. These filings may include information on the size and duration of repurchase authorizations and the company’s intention to fund them from cash and future cash flows.
On Stock Titan, TCMD filings are updated in near real time as they are posted to the SEC’s EDGAR system. AI-powered summaries highlight key points from lengthy documents, helping users quickly understand topics such as segment performance, capital allocation decisions and risk factor discussions without reading every page. Users can also review insider-related filings, including Forms 3, 4 and 5, to track equity transactions by directors and officers, and proxy statements on Schedule 14A for information on governance and executive compensation.
Whether you are analyzing Tactile Medical’s financial history, monitoring new 8-K disclosures or looking for details on its at-home therapy business, this page centralizes the company’s official SEC filings with concise AI-generated insights.